
Results
11
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
11 companies
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩408,000.00
7D
7.9%
1Y
-38.6%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,000.00
7D
6.2%
1Y
14.2%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,800.00
7D
15.5%
1Y
15.0%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,800.00
7D
0.2%
1Y
-5.5%
Myung In Pharmaceutical
Market Cap: ₩705.9b
A pharmaceutical company, manufactures ETC and OTC drugs.
A317450
₩48,350.00
7D
11.4%
1Y
n/a
JW Holdings
Market Cap: ₩289.2b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,180.00
7D
9.7%
1Y
21.7%
Chong Kun Dang Holdings
Market Cap: ₩192.8b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩40,500.00
7D
3.2%
1Y
-15.9%
Ilyang PharmaceuticalLtd
Market Cap: ₩157.7b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,800.00
7D
4.1%
1Y
-32.0%
Sinsin Pharmaceutical
Market Cap: ₩68.0b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,485.00
7D
4.3%
1Y
-20.8%
RP Bio
Market Cap: ₩55.6b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩6,410.00
7D
3.6%
1Y
4.2%
Korean Drug
Market Cap: ₩38.2b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,500.00
7D
3.9%
1Y
-25.3%